“…In addition, we also reported that autoimmune disorders have a major impact on T cell calcium homeostasis. During the short-term activation of peripheral T cells in patients with rheumatoid arthritis (RA) [12], multiple sclerosis [13] and type 1 diabetes [14], we found altered intracellular calcium kinetics, that were, at least partly, attributed to altered function and/or expression of lymphocyte potassium channels. We also demonstrated that some immune modulatory therapies, also used in CD, may have an impact on T cell function.…”